TABLE 5

Risk factors associated with the occurrence of side-effects#

Proportion with side-effects n/N (%)p-value for Chi-squared testAdjusted OR (95% CI)
Age years
 ≤60219/1273 (17.20)0.039Reference
 >60244/1193 (20.45)1.20 (0.97–1.47)
Sex
Female238/1121 (21.23)0.004Reference
Male225/1345 (16.73)0.73 (0.53–0.99)
BMI kg·m−2
<18.516/67 (23.88)0.059
18.5– <24211/1019 (20.72)
24– <28172/961 (17.90)
≥2864/419 (15.27)
ptrend0.0140.94 (0.91–0.97)
Ever-smoker
No293/1457 (20.11)0.041Reference
Yes170/1007 (16.85)0.99 (0.71–1.38)
Current alcohol drinking
No327/1701 (19.22)0.395
Yes136/765 (17.78)
Pulmonary fibrotic lesions
No451/2416 (18.67)0.068
Yes11/36 (30.56)
Fasting blood glucose mmol·L−1
≤7434/2295 (18.91)0.528
>729/171 (16.96)
History of silicosis
No449/2409 (18.64)0.257
Yes14/57 (24.56)
Concomitant with other drugs
No346/2066 (16.75)<0.001Reference
Yes117/400 (29.25)2.12 (1.65–2.71)

BMI: body mass index. #: side-effects were identified and graded by physicians using the Common Terminology Criteria for Adverse Events (version 4.0); : the events in the two intervention groups were pooled for this analysis.